Wheaton and Rockland Collaborate on Bioreactor Flasks: Less Work, More Titer

Date Posted:

Wheaton and Rockland Immunochemicals have collaborated on the development of bioreactor flasks that can help labs cut costs while providing high level results. Because of enhanced membrane technology, the CELLine Bioreactor Flask produces high quality results in a number of analyses, including Western Blot, ELISA and immunohistochemistry assays. This helps cut the costs of antibody development and production, while ensuring the target epitopes are still easily identified. To learn more about the CELLine product line or Rockland's collaboration with Wheaton, visit


View the Full Newsletter